Table 3.
Sites, numbers of metastases, and imaging modalities in 30 patients with MCC.
| Sites of metastasis | Number of patients (n (%)) | Multiple/ Solitary (n) | Imaging modality (n) | |
|---|---|---|---|---|
| Distant lymph nodes | 18 (60) | 15/3 | CT MRI US PET-CT | 22 3 2 1 |
| Liver | 9 (30) | 7/2 | CT PET-CT | 8 1 |
| Lungs | 9 (30) | 1/8 | CT PET-CT | 8 1 |
| Subcutaneous tissue | 8 (27) | 5/3 | CT MRI | 7 1 |
| Vertebral column and bones | 7 (23) | 4/3 | CT BSc MRI PET-CT | 3 2 1 1 |
| Pancreas | 6 (20) | 0/6 | CT | 6 |
| Brain or orbita | 4 (13) | 1/3 | CT MRI | 2 2 |
| Kidneys or adrenal glands | 3 (10) | 0/3 | CT BSc | 2 1 |
| Stomach | 2 (7) | 0/2 | CT | 2 |
| Heart | 1 (3) | 0/1 | CT | 1 |
| Retroperitoneal and peritoneal cavity | 3 (10) | 2/1 | CT | 3 |